Antibody classifications 3 and 4 were associated with at least minimal improvement at week 40, although the results were of borderline significance for classification 4 ( Supplementary Table S7 , available at Rheumatology online).
← all excerpts
Predictors of response to intravenous immunoglobulin in patients with dermatomyositis: the ProDERM study.
1
—
—